1. Home
  2. SLDP vs RZLT Comparison

SLDP vs RZLT Comparison

Compare SLDP & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SLDP

Solid Power Inc.

N/A

Current Price

$2.38

Market Cap

552.2M

Sector

Energy

ML Signal

N/A

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

N/A

Current Price

$4.85

Market Cap

471.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLDP
RZLT
Founded
2011
2010
Country
United States
United States
Employees
230
58
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.2M
471.0M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SLDP
RZLT
Price
$2.38
$4.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$6.88
★ $9.80
AVG Volume (30 Days)
★ 2.4M
1.7M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
5.56
★ 23.47
EPS
★ N/A
N/A
Revenue
★ $21,747,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.35
$2,481.32
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 7.98
N/A
52 Week Low
$1.98
$1.07
52 Week High
$8.86
$11.46

Technical Indicators

Market Signals
Indicator
SLDP
RZLT
Relative Strength Index (RSI) 49.44 66.61
Support Level $2.22 $4.36
Resistance Level $2.53 $5.43
Average True Range (ATR) 0.09 0.31
MACD -0.00 0.11
Stochastic Oscillator 49.12 93.48

Price Performance

Historical Comparison
SLDP
RZLT

About SLDP Solid Power Inc.

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Share on Social Networks: